185 related articles for article (PubMed ID: 34386335)
1.
Hou L; Liu Y; Liu W; Balash M; Zhang H; Zhang Y; Zhang H; Zhang Z
Acta Pharm Sin B; 2021 Jul; 11(7):2016-2030. PubMed ID: 34386335
[TBL] [Abstract][Full Text] [Related]
2. Enhanced Tumor-Specific Disulfiram Chemotherapy by
Wu W; Yu L; Jiang Q; Huo M; Lin H; Wang L; Chen Y; Shi J
J Am Chem Soc; 2019 Jul; 141(29):11531-11539. PubMed ID: 31251050
[TBL] [Abstract][Full Text] [Related]
3. Glutathione-responsive copper-disulfiram nanoparticles for enhanced tumor chemotherapy.
Chen M; Huang Z; Xia M; Ding Y; Shan T; Guan Z; Dai X; Xu X; Huang Y; Huang M; Zhao C
J Control Release; 2022 Jan; 341():351-363. PubMed ID: 34856225
[TBL] [Abstract][Full Text] [Related]
4. Disulfiram-loaded metal organic framework for precision cancer treatment via ultrasensitive tumor microenvironment-responsive copper chelation and radical generation.
Zhang H; Zhang Q; Guo Z; Liang K; Boyer C; Liu J; Zheng Z; Amal R; Yun SLJ; Gu Z
J Colloid Interface Sci; 2022 Jun; 615():517-526. PubMed ID: 35152072
[TBL] [Abstract][Full Text] [Related]
5. Copper-Enriched Prussian Blue Nanomedicine for In Situ Disulfiram Toxification and Photothermal Antitumor Amplification.
Wu W; Yu L; Pu Y; Yao H; Chen Y; Shi J
Adv Mater; 2020 Apr; 32(17):e2000542. PubMed ID: 32162734
[TBL] [Abstract][Full Text] [Related]
6. Nanomedicine Enables Drug-Potency Activation with Tumor Sensitivity and Hyperthermia Synergy in the Second Near-Infrared Biowindow.
Liu W; Xiang H; Tan M; Chen Q; Jiang Q; Yang L; Cao Y; Wang Z; Ran H; Chen Y
ACS Nano; 2021 Apr; 15(4):6457-6470. PubMed ID: 33750100
[TBL] [Abstract][Full Text] [Related]
7. Disulfiram-loaded copper sulfide nanoparticles for potential anti-glioma therapy.
Lan QH; Du CC; Yu RJ; Zhai J; Shi Y; Kou L; Xiao J; Lu CT; Zhao YZ; Yao Q
Int J Pharm; 2021 Sep; 607():120978. PubMed ID: 34371152
[TBL] [Abstract][Full Text] [Related]
8. Two birds with one stone: Copper metal-organic framework as a carrier of disulfiram prodrug for cancer therapy.
Pan Q; Xie L; Liu R; Pu Y; Wu D; Gao W; Luo K; He B
Int J Pharm; 2022 Jan; 612():121351. PubMed ID: 34883206
[TBL] [Abstract][Full Text] [Related]
9. Disulfiram Copper Nanoparticles Prepared with a Stabilized Metal Ion Ligand Complex Method for Treating Drug-Resistant Prostate Cancers.
Chen W; Yang W; Chen P; Huang Y; Li F
ACS Appl Mater Interfaces; 2018 Dec; 10(48):41118-41128. PubMed ID: 30444340
[TBL] [Abstract][Full Text] [Related]
10. Engineering of a double targeting nanoplatform to elevate ROS generation and DSF anticancer activity.
Li W; Huang H; Yao S; Zhao Y; Liu M; Liu X; Guo H
J Mater Chem B; 2024 Jun; ():. PubMed ID: 38904428
[TBL] [Abstract][Full Text] [Related]
11. Combination of Disulfiram and Copper-Cysteamine Nanoparticles for an Enhanced Antitumor Effect on Esophageal Cancer.
Chang Y; Wu F; Pandey NK; Chudal L; Xing M; Zhang X; Nguyen L; Liu X; Liu JP; Chen W; Pan Z
ACS Appl Bio Mater; 2020 Oct; 3(10):7147-7157. PubMed ID: 34179726
[TBL] [Abstract][Full Text] [Related]
12. DDTC-Cu(I) based metal-organic framework (MOF) for targeted melanoma therapy by inducing SLC7A11/GPX4-mediated ferroptosis.
Li C; Zhou S; Chen C; Zhu L; Li S; Song Z; Liang J; Tang C; Xu N; Liu T; Liu S
Colloids Surf B Biointerfaces; 2023 May; 225():113253. PubMed ID: 36934611
[TBL] [Abstract][Full Text] [Related]
13. Diethyldithiocarbamate-copper nanocomplex reinforces disulfiram chemotherapeutic efficacy through light-triggered nuclear targeting.
Ren L; Feng W; Shao J; Ma J; Xu M; Zhu BZ; Zheng N; Liu S
Theranostics; 2020; 10(14):6384-6398. PubMed ID: 32483459
[TBL] [Abstract][Full Text] [Related]
14. Co-delivery of a tumor microenvironment-responsive disulfiram prodrug and CuO
Cheng FT; Geng YD; Liu YX; Nie X; Zhang XG; Chen ZL; Tang LQ; Wang LH; You YZ; Zhang L
Nanoscale Adv; 2023 Jun; 5(12):3336-3347. PubMed ID: 37325521
[TBL] [Abstract][Full Text] [Related]
15. A CD44-targeted Cu(ii) delivery 2D nanoplatform for sensitized disulfiram chemotherapy to triple-negative breast cancer.
Gao Z; Li Y; Zhang Y; An P; Chen F; Chen J; You C; Wang Z; Sun B
Nanoscale; 2020 Apr; 12(15):8139-8146. PubMed ID: 32236229
[TBL] [Abstract][Full Text] [Related]
16. Self-supplying Cu
Gao Y; Cai X; Zou W; Tang X; Jiang L; Hao J; Zheng Y; Ye X; Ying T; Li A
RSC Adv; 2024 Apr; 14(19):13180-13189. PubMed ID: 38655468
[TBL] [Abstract][Full Text] [Related]
17. Disulfiram/copper induces antitumor activity against gastric cancer cells in vitro and in vivo by inhibiting S6K1 and c-Myc.
Du C; Guan X; Liu Y; Xu Z; Du X; Li B; Wang M; Zheng Z
Cancer Chemother Pharmacol; 2022 Apr; 89(4):451-458. PubMed ID: 35201421
[TBL] [Abstract][Full Text] [Related]
18. Disulfiram-loaded hollow copper sulfide nanoparticles show anti-tumor effects in preclinical models of colorectal cancer.
Jiapaer Z; Zhang L; Ma W; Liu H; Li C; Huang W; Shao S
Biochem Biophys Res Commun; 2022 Dec; 635():291-298. PubMed ID: 36327916
[TBL] [Abstract][Full Text] [Related]
19. Disulfiram loaded calcium phosphate nanoparticles for enhanced cancer immunotherapy.
Li Q; Chao Y; Liu B; Xiao Z; Yang Z; Wu Y; Liu Z
Biomaterials; 2022 Dec; 291():121880. PubMed ID: 36334355
[TBL] [Abstract][Full Text] [Related]
20. Recent Advances in Repurposing Disulfiram and Disulfiram Derivatives as Copper-Dependent Anticancer Agents.
Kannappan V; Ali M; Small B; Rajendran G; Elzhenni S; Taj H; Wang W; Dou QP
Front Mol Biosci; 2021; 8():741316. PubMed ID: 34604310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
